Metabolic Research Peptides
Metabolic Research
Triple receptor agonist research
Avenio Bio’s GLP-3™ series for laboratories studying GLP-1, GIP, and glucagon receptor co-activation.
Retatrutide + Bacteriostatic Water — pre-configured for in vivo research protocols.
What is metabolic peptide research?
Metabolic peptide research investigates how short amino acid sequences engage receptor systems involved in glucose homeostasis, energy expenditure, and lipid metabolism in laboratory models.
Retatrutide is a triple agonist — it engages GLP-1, GIP, and glucagon receptors simultaneously, a mechanism unique among current research compounds in this class. Earlier generations like semaglutide are GLP-1 mono-agonists; tirzepatide is dual GLP-1/GIP. Retatrutide adds glucagon receptor activity as a third target.
Questions about a research application?
info@aveniobio.comFor research use only. Not for human consumption. GLP-3™ is Avenio Bio’s internal series designation, not a regulatory drug class. Retatrutide is an investigational compound and is not approved by the FDA or any regulatory body for clinical or personal use. Avenio Bio products are sold exclusively for in vitro and laboratory research applications.